Introduction
Remote ischaemic conditioning (RIC), a manoeuvre consisting of short episodes of ischaemia-reperfusion applied in one vascular bed or tissue, has been shown to protect the heart against a lethal ischaemic insult. 1, 2 RIC efficacy has been suggested to be equivalent to that of classic, local, ischaemic preconditioning, [3] [4] [5] but some important differences in their mechanisms of action may exist, especially on signal transfer from the distant organ to the heart. 6, 7 The peripheral trigger is not restricted to ischaemia, but can be chemical, mechanical or electrical, [8] [9] [10] and signal transduction to the heart can be neutrally mediated or occur through the release to the bloodstream of one or several humoural factors.
1,2
The first evidence suggestive of the existence of a humoural factor comes from studies in which coronary effluent from an isolated rabbit heart, submitted to local ischaemic preconditioning, induced cardioprotection in a virgin acceptor heart. 11 The contribution for a blood-borne signalling factor in the cardioprotective effects of RIC was supported by studies showing that protection can be induced in pigs undergoing cardiac transplantation, where RIC application to the limb of the recipient animal was able to reduce infarct size in the later transplanted and denervated heart, 12 and in isolated rabbit hearts receiving plasma or plasma dialysate obtained from animals submitted to intermittent skeletal muscle ischaemia. 3 Moreover, RIC is able to exert cross-species cardioprotection, as has been demonstrated in isolated, Langendorffperfused, mouse or rabbit hearts treated with plasma dialysates obtained from human volunteers submitted to four cycles of intermittent upper arm ischaemia. 3, 9, 13 However, the exact chemical nature of these hypothetical humoural factors is currently unknown. Several studies have suggested that cardioprotective factors released by RIC should have molecular weights lower than 15 kDa. 3, 13 Protection might be dependent on the release from the distant tissue of extracellular vesicles that would serve as vehicles for the cardioprotective signals 14 and require opioid receptor activation. 3 Several putative candidates have been proposed, including matrix metalloproteinase-2 and -9 (MMP-2 and -9), 15 circulating nitrite 16 or microRNA-144, 17 whereas others have been discarded, as norepinephrine. 11 The role of adenosine remains controversial. 11, 18 Thus, the aim of this work was to identify, by 1 H-NMR spectroscopy, the chemical nature of any humoural factor released by the RIC manoeuvre in anesthetized pigs contributing to its cardioprotective effect in isolated mice hearts.
Methods
The present study conforms to the Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes and the NIH Guide for the Care and Use of Laboratory Animals (NIH publications no. 85-23, revised 1996, updated in 2011). The study was approved by the Ethics Committee of our institution (reference number: 13/15 CEEA).
RIC protocol in anesthetized pigs
Ten hybrid farm pigs (25-30 kg, 12 h fasting) were premedicated with tiletamine-zolazepam (4-6 mg/kg, IM) and xylazine (1-2 mg/kg, IM) and anesthetized with propofol-lipuro 1% (1.5-2.5 mg/kg, IV, followed by continuous infusion at 11 mg/kg/h) and fentanyl (5 lg/kg, IV, followed by continuous infusion at 3-6 lg/kg/h) and mechanically ventilated. Arterial blood gases, reflexes and lead II of electrocardiogram were continuously monitored to confirm adequate level of anaesthesia. One femoral artery was dissected free and surrounded by an elastic snare, whereas the ipsilateral femoral vein was cannulated to obtain a first, baseline, blood sample (60 mL) in heparinized tubes (10 U/mL). Ten minutes later, animals were submitted, using the elastic snare located around the femoral artery, to a RIC protocol consisting of four cycles of 5 min of lower limb ischaemia followed by 5 min of reperfusion, and blood (60 mL) was again obtained during the last 2 min of the manoeuvre (postRIC sample). This RIC protocol was previously shown to reduce infarct size in pigs submitted to transient coronary occlusion. 19 Leg incision was sutured by layers, and animals were treated with antibiotics (cefazolin (1 g, IM) and amoxicillin-clavulanic acid (150 mg/10 kg, IM)), anti-inflammatory drugs (meloxicam, 0.2 mg/kg, IM) and analgesics (buprenorphine, 0.05 mg/kg, IV)) and returned to our animal facility for recovery. One week later, animals were submitted to the same protocol in the contralateral leg, and afterwards sacrificed by sodium thiopental overdose (100 mg/kg, IV). 
Plasma dialysate preparation

1 H-NMR spectroscopy of porcine plasma dialysates
To confirm the effectiveness of the dialysis process and to assess any possible difference in the chemical composition of baseline and postRIC samples, plasma metabolites were analyzed by 1 H-NMR spectroscopy (n = 12/group). Plasma dialysates were initially lyophilized, and then resuspended in 600 ll of deuterium oxide containing 1 mmol/L TSP (3-(trimethylsilyl)propionic-2,2,3,3-d 4 acid sodium salt), added as internal and chemical shift standard. 20 1 H-NMR spectra were acquired on a vertical bore 9.4T magnet interfaced to a Bruker Avance 400 spectrometer. Each spectrum consisted in the accumulation of 64 scans using a fully relaxed pulse-and-acquire pulse sequence with presaturation of the residual water signal. 20 In some of the samples, exogenous glycine was added to confirm identity of this metabolite within the NMR spectra. 21 Left ventricular (LV) pressure was monitored with a water-filled latex balloon placed in the left ventricle, inflated to obtain an end-diastolic left ventricular pressure (EDLVP) between 6 and 8 mmHg, and connected to a pressure transducer. Perfusion pressure was continuously recorded using a pressure transducer connected to the perfusion line. Before perfusion of the isolated mice hearts with plasma dialysates, they were added with glucose and NaHCO 3 to a final concentration of 11 and 25 mmol/L, respectively, and filtered through a 0.2 lm filter. Isolated mice hearts were either treated, for 30 min before ischaemia (n = 12/group), or during the first 15 min of reperfusion (n = 6/group), with baseline or postRIC porcine plasma dialysate obtained from six pigs, and results were compared between both groups. Hearts treated before ischaemia were perfused with plasma dialysates coming from both pig intervention, but those treated during reperfusion were perfused only with that obtained during the first intervention. Treatment during reperfusion was shorter than before ischaemia, as most of cell death occurring during ischaemia-reperfusion injury takes placed during the first minutes of reperfusion, as denoted by LDH release analysis. 21, 22 In an attempt to increase the efficacy of postRIC dialysates when given during initial reperfusion, plasma from four additional pigs was obtained during the first minute of each RIC cycle, combined, and applied to four isolated mice hearts, and results were compared with those obtained in four hearts treated with baseline dialysate.
Ischaemia-reperfusion injury in isolated mice hearts
Experimental preparation
Ischaemia-reperfusion injury and study protocols
In accordance with our 1 H-NMR analysis, which demonstrated a marked increase in glycine concentrations in porcine plasma samples obtained after RIC, and to assess a possible role of this amino acid in the cardioprotective effects of postRIC plasma dialysates, 10 mice hearts were treated, after stabilization, with Krebs containing 10 lmol/L strychnine, a glycine receptor inhibitor, for 5 min, that were immediately followed by 30 min of perfusion with baseline or postRIC plasma dialysate, also added with 10 lmol/L of strychnine (n = 5/group). Hearts were then submitted to the period of global ischaemia-reperfusion, as above. The concentration of strychnine used was previously shown to effectively depress depolarizing responses to glycine in rat spinal cord. 23 Finally, we tried to mimic protection induced by pretreatment with postRIC dialysate with Krebs buffer containing glycine at 0.05 (concentration found in baseline plasma dialysate), 0.5 (concentration found in postRIC plasma dialysate) or 3 mmol/L (a concentration previously shown to prevent necrotic cell death in isolated HL-1 cardiomyocytes submitted to simulated ischaemia 24 ), either in the absence or the presence of strychnine 10 lmol/L, or 100 lmol/L disodium succinate (almost the concentration found in postRIC samples, and that was increased compared with baseline dialysates), and results were compared with those obtained in a control group (n = 6-7/group).
Specificity of strychnine has been described not to be limited to glycine receptors. Strychnine has been shown to antagonize nicotinic receptors in bovine adrenal medullary chromaffin cells, 25 and to act as an allosteric ligand at muscarinic receptors, decreasing its affinity for acetylcholine. 26 As some data point to a role for cholinergic receptors in dialysate-mediated protection, 27 we additionally assessed, in our isolated mice heart model, and under normoxic conditions, the effects of acetylcholine (from 10 -9 to 10 -4 mol/L) on left ventricular pressure and heart rate in the absence or the presence of strychnine 10 lmol/L (n = 3/group).
LDH release and infarct size measurement
LDH release was monitored during reperfusion by spectrophotometry in samples obtained from the coronary effluent, as previously described. 21 Infarct size was measured in cardiac slices by 2,3,5-triphenyltetrazolium chloride (TTC) staining at the end of reperfusion. 
Results
Our RIC protocol was previously shown to reduce infarct size in pigs submitted to 40 min of coronary occlusion followed by 2 h of reperfusion, from 59.21 ± 3.17% in control animals (n = 10) to 36.50 ± 4.72% in pigs treated with RIC during the ischaemic period (n = 7) (Student's t test, P < 0.001), 19 an effect that was additive with that of pharmacological treatments aimed to modulate myocardial metabolism (as glucose-insulin-potassium or exenatide).
1
H-NMR spectroscopy of porcine plasma dialysates Figure 1A shows a representative 1 H-NMR spectra obtained from a porcine baseline plasma dialysate, showing the presence of several peaks corresponding to the different metabolites analyzed. Supervised classification (OPLS-DA) was able to discriminate between plasma samples obtained before and after RIC application (Q 2 = 0.126). The model properly classified 78.26% of plasma samples (P = 0.0095, Fisher's exact test). These results demonstrate that baseline and postRIC plasma samples have a different metabolic profile. Table 1 shows the main metabolites obtained by NMR analysis. PostRIC plasma samples showed a significant increase in lactate, succinate, and glycine concentrations, as compared with baseline samples ( Figure 1A-D) .
Effects of postRIC plasma on ischaemia-reperfusion injury in isolated mice hearts
Left ventricular function
Baseline LVdevP, EDLVP, and perfusion pressures ranged among 80-120, 0-10, and 80-100 mmHg, respectively, with no differences between groups. Heart rate was also similar, and oscillated between 300 and 400 beats per minute. Ischaemia induced, in all groups, a marked reduction in LVdevP, reaching a minimum 2-3 min later. Ischaemic rigor contracture, detected as an abrupt increase in EDLVP, occurred during the first minutes of ischaemia, with no differences between groups.
Pretreatment with postRIC plasma dialysate tended to improve functional recovery at the end of reperfusion in isolated mice hearts, as compared with control hearts pretreated with baseline plasma dialysate ( Figure 2A) . In contrast, no trend was observed in hearts treated with postRIC plasma dialysates at the onset of reperfusion ( Figure 3A) .
Infarct size
LDH release ( Figure 2B and C) and infarct size ( Figure 2E ) were significantly reduced in hearts pretreated with postRIC plasma dialysate, as compared with those treated with baseline plasma dialysate ( Figure 2B , C and E). In contrast, treatment with postRIC plasma dialysates at the onset of reperfusion did not result in protection against reperfusion injury ( Figure 3B-D) . Similarly, plasma dialysates obtained during the first minute of each RIC cycle also failed to induce protection when applied at the onset of reperfusion [54.5 ± 9.9% vs. 49 .5 ± 9.1% in control hearts (n = 4/group, P-NS)].
Mechanisms of protection by pretreatment with porcine postRIC plasma dialysates
To assess the involvement of glycine in the cardioprotective effects of postRIC plasma dialysates, when given before ischaemia, isolated mice Figure 2D and F, the glycine receptor antagonist abolished the cardioprotective effect induced by pretreatment with postRIC plasma dialysate, both on infarct size and on LDH release. Furthermore, pretreatment with glycine 3 mmol/L (but not 0.050 or 0.50 mmol/L), added to the Krebs buffer, was shown to mimic protection induced by porcine postRIC plasma dialysates (Figure 4) , an effect that was blocked by strychnine 10 lmol/L (Figure 4) .
Succinate was also increased in plasma samples obtained after RIC application. To test the involvement of this metabolite on the cardioprotective effect of postRIC plasma dialysates, isolated mice hearts were pretreated, for 30 min before ischaemia, with Krebs buffer containing or not succinate 100 lmol/L. However, succinate was not able to reduce infarct size (Figure 4) .
Strychnine 10 lmol/L, which slightly reduced heart rate in isolated mice hearts (from 374.51 ± 36.20 beats per minute under control conditions to 302.48 ± 47.33 after strychnine, Student's t test, P = 0.026), did not modify responses to acetylcholine. Acetylcholine induced a concentration-dependent reduction of heart rate, both in the absence and in the presence of strychnine, with no differences between groups when expressed as percentage of corresponding baseline value ( Figure 5) . No differences were observed on LVdevP. 
DISCUSSION
Our present results demonstrate that RIC alters the metabolic profile of plasma in anesthesized pigs, with increased lactate, succinate, and glycine being the main metabolites responsible for its distinctive metabolic fingerprint. Moreover, plasma dialysates obtained after RIC are cardioprotective in isolated mice hearts, and this effect is abolished by glycine receptor antagonists and reproduced by addition of glycine, but not succinate, to the perfusate. These results indicate that the cardioprotective effect of RIC is mediated, at least in part, through remote glycine release and myocardial glycine receptor activation.
1 H-NMR spectroscopy of porcine plasma dialysates
The mechanisms of RIC protection have not been fully elucidated. Signal transduction to the heart has been suggested to occur either through neural pathways or through the release to the bloodstream of one or several humoural factors.
1,2 In fact, both pathways can be interconnected, as the protective effect of RIC has been shown to be attenuated in diabetic patients with peripheral neuropathy, but not in those without it. 13 In addition, the cardiac protective effect of RIC application to both hind limbs has been shown to be dependent, in adult rats, on intact visceral innervation, suggesting that circulating factors are released into systemic circulation from these organs. 28 Identifying the nature of circulating RIC factors is of great interest, as it would allow its use as a mainstream cardioprotective strategy in STEMI patients. Previous studies have suggested that humoural factors released by RIC have molecular weights lower than 15 kDa, 3, 13 and that they may be transported through extracellular vesicles. 14 Several candidates have been proposed, including opioids, 3 matrix metalloproteinase-2 and -9 (MMP-2 and -9), 15 circulating nitrite, 16 or microRNA-144. 17 In our present study, we have demonstrated, using 1 H-NMR spectroscopy analysis, that baseline and postRIC plasma samples are metabolically different, and that RIC induces an increase in lactate, succinate and glycine concentrations in pig plasma.
Glycine is involved in RIC protection
Glycine is the smallest amino acid and a major inhibitory neurotransmitter in vertebrate central nervous system. 29 Previous studies have demonstrated that glycine exerts protective effects against necrotic and apoptotic cell death induced by diverse insults, including ischaemiareperfusion injury, in different cell types and tissues other than myocardium. [30] [31] [32] [33] [34] [35] However, the mechanisms of these effects remain elusive. Glycine has been shown to delay sarcolemmal rupture induced by reoxygenation after hypoxia in hepatocytes, an effect that was initially explained by attenuated accumulation of Na þ related to stimulation of glycine-gated Cl -channels. 36 In contrast, others suggested a receptorindependent mechanism of protection for glycine, related to closure of non-specific sarcolemmal pores opened during hypoxia. 30, 31, 37 In previous studies, we found that glycine prevented mitochondrial permeability transition, as detected by increased calcein release from mitochondria, an effect that was associated with a reduction in necrotic cell death during simulated reperfusion. 24 In rat-isolated mitochondria, glycine prevented cyclosporine-sensitive swelling, further suggesting that glycine inhibits opening of mitochondrial permeability transition pore. 24 A similar attenuation of mitochondrial dysfunction associated with ischaemiareperfusion was observed in rat lungs 38 and rabbit livers. 39 Furthermore, glycine is also protective against myocardial necrosis induced by prolonged hypoxia or hypoxia-reoxygenation in isolated rat hearts, an effect shared by acidosis, 24, 40 whereas pretreatment with glycine has been shown to reduce infarct size and apoptosis in an open-chest anesthetized rat model. 41 The fact that the concentrations of glycine found in our NMR analysis in plasma samples obtained after RIC application was in the same range as that previously shown to be protective in isolated cardiomyocytes and rat hearts, 24 makes glycine a good candidate to be one of the humoural factors involved in RIC protection. In fact, when isolated mice hearts were pretreated with strychnine, a glycine receptor antagonist, 23 the observed cardioprotective effect induced by postRIC plasma dialysate was abolished, whereas pretreatment with glycine 3 mmol/L mimicked protection. Unfortunately, glycine 500 lmol/L, the concentration found in postRIC plasma dialysates, was not able to reduce infarct size in our isolated, Langendorff-perfused, mice heart model, and glycine concentrations of 3 mM or larger were necessary to attenuate reperfusion injury. Although this concentration is less than one order of magnitude higher than that found in postRIC plasma dialysates, it is not clear why glycine 500 lM was not effective reducing infarct size. PostRIC blood was obtained during the last 2 min of the manoeuvre, and it is possible that in some animals the peak of glycine release could take place slightly earlier or later. In addition, we cannot exclude the possibility that glycine was acting in an additive manner with other humoural factors released by the manoeuvre and not detected by NMR. On the contrary, our data correlate well with those previously found in an in vivo mice model of ischaemic preconditioning in mice submitted to transient occlusion of the left descending coronary artery. 42 In this model, wild-type preconditioned animals depicted an increase in cardiac glycine concentrations compared with control animals, 42 but this increase was abolished in PKC-d -/-animals, that could not be preconditioned. This may indicate a general response of the organism to endogenous cardioprotection. Altogether, these data may support the hypothesis that the cardioprotective effect of RIC is, at least in part, mediated by glycine receptor activation. Furthermore, the effects of glycine on RIC protection may extend beyond the cardiovascular system. Indeed, glycine has been shown to be protective in other tissues, including liver, lung, and kidneys. [30] [31] [32] [33] [34] [35] In any case, we have to acknowledge that the lack of effect of the lower concentration may indicate that glycine may be a necessary, but not sufficient mediator of RIC's protection. Previous studies have shown that strychinine may have actions on receptors other than that of glycine. Strychnine was demonstrated to antagonize nicotinic receptors in bovine adrenal medullary chromaffin cells, 25 and to act as an allosteric ligand at muscarinic receptors, decreasing its affinity for acetylcholine. 26 As cholinergic receptors may play a role in dialysate-mediated protection, 27 we assessed whether the effects of acetylcholine on cardiac function is maintained in the presence of strychnine. Accordingly, we showed that acetylcholine induced a concentration-dependent decrease in heart rate that was not affected by the glycine-receptor antagonist, suggesting that strychnine, at the concentration and conditions used in the present study is rather selective for glycine receptors.
RIC protection is not dependent on succinate release
In addition to glycine, postRIC plasma samples showed an increase in succinate and lactate concentrations. Succinate has been previously proposed to be a universal metabolic signature of ischaemia, 43 and accumulates in the area at risk due to conversion of fumarate by reversal of succinate dehydrogenase. 22, 43 Upon reperfusion, rapid succinate reoxidation by forward succinate dehydrogenase activity was shown to induce a massive ROS production, due to reverse electron transport from mitochondrial complex II to complex I. 43 Importantly, inhibition of succinate accumulation during ischaemia 43 or of succinate dehydrogenase activity during reperfusion 22 has been shown to be protective against ischaemia-reperfusion injury. However, our present data seem to discard a role for succinate in RIC protection, as pretreatment with this metabolite did not mimic the reduction in infarct size observed in isolated mice hearts pretreated with postRIC plasma dialysate. It is probably that the described increase in succinate concentrations in plasma merely reflects the increase in its concentration in the myocardium due to tissue ischaemia (as would also happen with lactate). Succinate concentrations have been shown to drop in cardiac tissue after ischaemic preconditioning both in wild-type mice and in PKC-d -/-animals, that could not be preconditioned, 42 further suggesting that succinate is not involved in endogenous protection.
Pre-vs. post-conditioning
Most studies demonstrating the existence of humoural factors responsible for RIC protection have been conducted in isolated, Langendorffperfused, heart models, by application of dialysates or coronary effluents before ischaemia in the recipient heart. 3, 9, 11, 13, 14, 16, 18, 44, 45 To our knowledge, a single study has tested the effect of administration of coronary effluents, obtained during ischaemic preconditioning cycles in isolated rat hearts, at the onset of reperfusion. 45 In contrast, in our present study, we were only able to observe protection when porcine postRIC plasma dialysates were applied before ischaemia in isolated mice hearts, but not at the onset of reperfusion. The protocol we used to obtain plasma dialysates is similar to that previously described. 3, 9, 13 Moreover, we tried to increase the concentrations of any humoural factor present in plasma by taking blood samples at each of the RIC cycles (instead of during the last reperfusion), but this attempt was also unsuccessful. This result contrasts with the well proven cardioprotective effect of RIC in pre-clinical and clinical models. 19, [46] [47] [48] A potential explanation is that the isolated, perfused mice heart model is less sensitive to humoural RIC protection than the heart of an intact animal were RIC has been performed. Alternatively, the mechanisms of remote ischaemic post-conditioning could be different from those of remote ischaemic pre-conditioning, as being more dependent on neural pathways.
Study limitations
Plasma blood samples were obtained from pigs anesthetized with propofol, a drug that has been described to interfere with RIC cardioprotection in patients undergoing coronary artery bypass surgery. 49 However,
we have previously shown that despite the use of this anaesthetic RIC was still protective, inducing a 40% reduction in infarct size in pigs. 19 When we applied porcine plasma dialysates before ischaemia, they were obtained from two different interventions in our pig model that was spaced 1 week. One may think that humoural factors may still be circulating after that period, which would influence interpretation of our findings. However, when we compared pig plasma samples obtained during the first intervention with those obtained during the second one, we were not able to detect any difference in the concentrations of the different metabolites (see Figure 1) . This may be in agreement with the findings of Hildebrandt et al. 50 , as they observed protection by transfer of plasma dialysates obtained from healthy volunteers 6 days after RIC application, but not 7 days after it. Glycine measurements in our 1 H-NMR analysis show a great variability. Part of this variability may have originated during manipulation of the samples, especially during the dialysis procedure or during lyophilizaton and resuspension. However, it is also plausible that an important part can be biological variability. Indeed, blood samples were obtained during the last 2 min of the manoeuvre, and, as explained before, it is possible that in some pigs the peak of glycine release could take place with some delay or advance. However, when postRIC plasma dialysates were applied to isolated mice hearts, most of them showed clear protection, which may indicate that glycine is not the only mechanism of protection. 1 H-NMR detects a limited number of metabolites, which is dependent on the magnetic field strength (in our case 9.4T) and on the own nature of the technique (metabolites with very low concentrations will not be detectable). Accordingly, we cannot discard that other metabolites could be affected by the RIC manoeuvre and involved in its protection. In this sense, our technique, together with the use of plasma dialysis membranes with a pore of 12-14 kDa, makes unlikely to detect changes in nitrites (they lack protons susceptible to be identified), microRNAs or extracellular vesicles, previously shown to be involved in RIC protection. 14, 16, 17 However, compared with other metabolomic techniques, as mass spectrometry, NMR has a high specificity and reproducibility, and is less affected by sample manipulation, which makes the detected changes in glycine concentrations very solid. The only exception would be targeted mass spectrometry, in which the combined use of precursor and product ions, along with robust chromatography, imparts a high degree of reliability to the data. 51 Unfortunately, this technique is still not available in most laboratories.
In conclusion, the present results identify glycine as a humoural factor of RIC protection.
